266 related articles for article (PubMed ID: 19444783)
1. Restrictions on business relationships with industries, and their unintended adverse consequences.
Sataloff RT
Ear Nose Throat J; 2009 May; 88(5):904-8. PubMed ID: 19444783
[No Abstract] [Full Text] [Related]
2. Biased articles.
Friedman JH
Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
[No Abstract] [Full Text] [Related]
3. Conflict of interest, round 2.
Freedman R; Lewis DA; Michels R; Pine DS; Schultz SK; Tamminga C; Patterson SL; McIntyre JS; Goldman HH; Yudofsky SC; Hales RE; Rapaport MH; Hales D; Krajeski J; Kupfer DJ; Badaracco MA; Scully JH
Am J Psychiatry; 2006 Sep; 163(9):1481-3. PubMed ID: 16946167
[No Abstract] [Full Text] [Related]
4. Conflict of interest, disclosure, and trial reports.
Psaty BM
JAMA; 2009 Apr; 301(14):1477-9. PubMed ID: 19351946
[No Abstract] [Full Text] [Related]
5. Conflicts of interest and access to information from medical research.
Byk C
Bull Med Ethics; 2002 Apr; (177):18-9. PubMed ID: 12691105
[No Abstract] [Full Text] [Related]
6. Extent and impact of industry sponsorship conflicts of interest in dermatology research.
Perlis CS; Harwood M; Perlis RH
J Am Acad Dermatol; 2005 Jun; 52(6):967-71. PubMed ID: 15928613
[TBL] [Abstract][Full Text] [Related]
7. Industry and medicine: conflicting interests and the power of money.
Popovsky MA; Garcia N
Transfusion; 2007 Jun; 47(6):1098-9. PubMed ID: 17524103
[No Abstract] [Full Text] [Related]
8. [Series: For attending physicians: seeking to understand the diversity of medicine; conflict of interest in medical practice and education].
Miyata Y
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2733-40. PubMed ID: 24400558
[No Abstract] [Full Text] [Related]
9. Financial relationships between research and pharmaceutical/biotech companies: disclosure is imperative.
Caughey AB; Urato AC
Am J Obstet Gynecol; 2007 Jan; 196(1):e13; author reply e13-4; discussion e14. PubMed ID: 16959207
[No Abstract] [Full Text] [Related]
10. Industry-sponsored research.
Okike K; Kocher MS; Mehlman CT; Bhandari M
Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
[TBL] [Abstract][Full Text] [Related]
11. Medicine and the pharmaceutical industry.
Baxter P
Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
[No Abstract] [Full Text] [Related]
12. Sponsorships for medical specialists.
Magotra R
Issues Med Ethics; 1997; 5(4):122-5. PubMed ID: 16267917
[No Abstract] [Full Text] [Related]
13. [The influence of the pharmaceutical industry on treatment guidelines].
Kramers C; Wuis E; Schouwenberg B
Ned Tijdschr Geneeskd; 2008 Jan; 152(2):114; author reply 114. PubMed ID: 18265803
[No Abstract] [Full Text] [Related]
14. Who pays the piper?
Friedli L
Ment Health Today; 2003 Nov; ():8-9. PubMed ID: 14689593
[No Abstract] [Full Text] [Related]
15. Conflicts of interest. A golden standard to generalize in addiction research.
Gual A
Addiction; 2010 Feb; 105(2):199-200; author reply 205-6. PubMed ID: 20078473
[No Abstract] [Full Text] [Related]
16. Ethical issues in the relationships with industry: an ongoing challenge. New Guidelines open for public comment.
Komesaroff PA
J Paediatr Child Health; 2005 Nov; 41(11):558-60. PubMed ID: 16398836
[TBL] [Abstract][Full Text] [Related]
17. Conflict of interest in industry-sponsored drug development.
Emanuel EJ
Clin Adv Hematol Oncol; 2007 Apr; 5(4):265-7. PubMed ID: 17607285
[No Abstract] [Full Text] [Related]
18. [A sunshine story].
Haug C
Tidsskr Nor Laegeforen; 2010 May; 130(9):919. PubMed ID: 20453939
[No Abstract] [Full Text] [Related]
19. Fear of influence: conflict of interest in biomedical and genetic research.
Shamoo AE; Cole JW
Genewatch; 2004; 17(4):12-3. PubMed ID: 15460599
[No Abstract] [Full Text] [Related]
20. [For and against: does sponsoring impede the growth of knowledge in medicine?].
Finzen A; Fritze J
Psychiatr Prax; 2007 May; 34(4):162-4. PubMed ID: 17520527
[No Abstract] [Full Text] [Related]
[Next] [New Search]
